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Abstract 38 
This study determined the effectiveness of antioxidant supplementation on high intensity 39 
exercise-heat stress. 40 
Six males completed a high intensity running protocol twice in temperate conditions (TEMP; 41 
20.4°C), and twice in hot conditions (HOT; 34.7°C). Trials were completed following seven 42 
days supplementation with 70mL.day-1 effective microorganism-x (EM-X; TEMPEMX or 43 
HOTEMX) or placebo (TEMPPLA or HOTPLA). Plasma extracellular Hsp72 (eHsp72) and 44 
superoxide dismutase (SOD) were measured by ELISA.   45 
eHsp72 and SOD increased pre-post exercise (p<0.001), with greater eHsp72 (p<0.001) 46 
increases observed in HOT (+1.5ng.mL-1) compared to TEMP (+0.8ng.mL-1). EM-X did not 47 
influence eHsp72 (p>0.05). Greater (p<0.001) SOD increases were observed in HOT 48 
(+0.22U.mL-1) vs. TEMP (+0.10U.mL-1) with SOD reduced in HOTEMX vs. HOTPLA 49 
(p=0.001). Physiological and perceptual responses were all greater (p<0.001) in HOT vs. 50 
TEMP conditions, with no difference followed EM-X (p>0.05). 51 
EM-X supplementation attenuated the SOD increases following HOT, potentiating its 52 
application as an ergogenic aid to ameliorate oxidative stress. 53 
 54 
 55 
 56 
 57 
 58 
 59 
Introduction 60 
Increased extracellular heat shock protein 72 (eHsp72) concentrations are evident in response 61 
to exercise (Yamada, Amorim, Moseley, & Schneider, 2008) with the greater increases 62 
during exercise-heat stress predicted by the magnitude of change in rectal temperature 63 
(Gibson et al., 2014) and exercise intensity (Periard, Ruell, Caillaud, & Thompson, 2012). 64 
Reactive oxygen species generation and/or disturbances to redox balance are essential 65 
components of adaption (Powers, Duarte, Kavazis, & Talbert, 2010). Conversely, their 66 
presence can induce performance decrements when repeated demanding exercise is required 67 
with insufficient recovery (Cobley, McGlory, Morton, & Close, 2011) i.e. during tournament 68 
competition or within consecutive day, multiday events. Oxidative stress can inhibit the onset 69 
of tissue repair (Ascensao et al., 2008) with chronic oxidative stress coinciding with skeletal 70 
muscle atrophy (Powers, et al., 2010). Amelioration of short-term negative effects of 71 
oxidative stress on demanding exercise with limited recovery time could be advantageous, 72 
thus this paradigm (exercise-heat stress; redox balance; Hsp72) requires exploration. N-73 
Acetylcysteine supplementation can achieve this goal, though nausea and gastrointestinal 74 
discomfort can present (Cobley, et al., 2011), reducing its practicality. At present, there is no 75 
literature directly assessing the interplay between oxidative stress/redox balance disturbances 76 
and eHsp72 expression in vivo, though redox disturbances preceding increases in intracellular 77 
Hsp72 (iHsp72) are well reported (Taylor et al., 2012). 78 
Antioxidant supplementation may hypothetically blunt the exercise induced eHsp72 response 79 
in a similar manner to that seen with hypoxic preconditioning and iHsp72 (Taylor, et al., 80 
2012), in addition to antioxidant mediated ergogenicity specific to high-intensity interval 81 
training (HIT) type exercise (Cobley, et al., 2011). Effective Microorganism X (EM-X) has 82 
potent antioxidant effects (Deiana et al., 2002; Do, Seo, Hwang, Kim, & Nam, 2007). The 83 
antioxidant cocktail (EM-X) is derived from effective microorganisms of lactic acid bacteria, 84 
yeast and photosynthetic bacteria (Aruoma et al., 2002) and presents no mutagenic effects 85 
under chronic or acute supplementation (Ke, Liang, Zhong, Higa, & Aruoma, 2005). EM-X 86 
administration increases serum dismutase, decreases malondialdehyde (Deiana, et al., 2002), 87 
whilst, resisting acute severe oxidative stress mediated damage in the kidney and liver of rats 88 
(Aruoma, et al., 2002), and conveying an anti-inflammatory influence at a cellular level, 89 
independent of antioxidant activity (Do, et al., 2007). Given the potent stimuli that exercise 90 
(Yamada, et al., 2008), exercise-heat stress (Gibson, et al., 2014) and disturbances to redox 91 
(Taylor, et al., 2012) represent for HSP induction, supplementation of EM-X may affect 92 
exercise induced disturbances to redox balance, thus the HSP exercise response. HIT specific 93 
exercise-heat stress induced fatigue, as shown elsewhere with N-Acetylcysteine (Cobley, et 94 
al., 2011), may be attenuated with EM-X supplementation by reducing disturbances to redox 95 
balance (Aruoma, et al., 2002; Aruoma et al., 2003; Deiana, et al., 2002) and pro-96 
inflammatory cascades (Do, et al., 2007). 97 
The aims of the present study are to investigate; i) the influence of HIT on eHsp72 98 
concentration and plasma superoxide dismutase (SOD) activity; ii) the influence of ambient 99 
temperature (thermoneutral/hyperthermic) on any HIT induced alterations in basal eHsp72 100 
concentration and plasma SOD activity; iii) the influence of EM-X supplementation on HIT 101 
induced eHsp72 concentration and plasma SOD activity within both environmental 102 
conditions (thermoneutral/hyperthermic). 103 
Methods 104 
Subjects and general experimental controls/methods:  105 
Six male subjects (mean ± SD: age 22.0 ± 1.3 years; height 181.0 ± 4.19 cm; mass 73.5 ± 3.1 106 
kg; maximum oxygen uptake (VO2max) 51.7 ± 7 mL.kg-1.min-1) volunteered to participate 107 
within the present study. Subjects attended the laboratory at the same time of day to minimise 108 
circadian variation on performance (Reilly et al., 2007; Winget, Deroshia, & Holley, 1985). 109 
The confounding variables of hypoxic, thermal and hyperbaric exposures, and smoking, 110 
glutamine, caffeine, alcohol and generic supplementation were all controlled in line with 111 
previous HSP/redox balance exercise projects within the field (Taylor, et al., 2012).  112 
Prior to reporting to the laboratory, subjects were instructed to drink 500 mL of water 2 hrs 113 
prior to all laboratory visits, in accordance with the ACSM position stand (Sawka et al., 114 
2007). Upon arrival at the laboratory the subjects provided a urine sample for assessment of 115 
specific gravity to determine hydration status using dip test strips (Combur10-test, Roche 116 
Diagnostics, Mannheim, Germany). Nude body mass was assessed (Tanita BWB-800, Tokyo, 117 
Japan), a rectal temperature probe was inserted at a depth of 10 cm past the anal sphincter 118 
(Libra Medical, Reading, UK) and a HR monitor was affixed to the chest (Polar Sports 119 
Tester, Polar Electro Oy, Kempele, Finland). 120 
High intensity interval running protocol (HITRP): The protocol consisted of 20 fast high 121 
intensity runs 10 seconds in duration at a velocity corresponding to the final running speed 122 
achieved during the Maximal Anaerobic Running Test (MART) test (23.0 ± 1.8 km.h-1). with 123 
80 seconds of active recovery at a velocity corresponding to 35% VO2max (6.7 ± 2.2 km.h-1) 124 
and lasted  approximately 40 minutes (37.3 ± 3.5 minutes). The high intensity running speed 125 
was supramaximal in relation to the VO2max test. Heart rate (HR) was recorded following 126 
each 10 second run and 60 seconds into recovery. Ratings of perceived exertion (RPE; (Borg, 127 
Ljunggren, & Ceci, 1985)), thermal sensation (TS; (Gagge, Stolwijk, & Saltin, 1969)) and 128 
core temperature (Tc) were recorded 60 seconds into recovery. Venous whole blood samples 129 
were obtained at rest before commencement of the sprint protocol and immediately upon 130 
completion of the sprint protocol, descriptions of collection and analysis is detailed in Venous 131 
blood sampling, eHsp72 and SOD measurement below. 132 
Venous blood sampling, eHsp72 and SOD measurement: In line with previous work in the 133 
field (Gibson, et al., 2014) a 10 mL whole venous blood sample was drawn from the 134 
antecubital fossa. Each sample was divided equally into 5 mL tubes (Starstedt, Germany) 135 
containing EDTA (Vacuette®, Greiner BIO-one, UK). Whole blood samples were 136 
centrifuged (Eppendorf 5804 R Centrifuge) at 4,500 rpm for 15 min to separate plasma. 137 
Plasma was pipetted (Eppendorf Research/Research Pro) into 1.5 mL microtubes (Eppendorf) 138 
and stored at -86°C (Sanyo Ultra Low, VIP Series) until analysis. 139 
eHsp72 analysis utilised a commercially available pre-prepared Enzyme-Linked 140 
Immunosorbent Assay (ELISA) kit in line with manufacturer’s instructions (Stress Express 141 
HSP70 High sensitivity ELISA kit, EKS-715, Stressgen Bioreagents, Victoria, Canada) 142 
utilising a plate reader (ELx800, Bio-Tech Instruments, Inc. Winoski, USA) and read at an 143 
absorption of 450 nm. The sensitivity of the ELISA kit was 0.09 ng/mL and both inter- and 144 
intra-assay coefficient of variation was 3.2%, in line with previous work in the field (Gibson, 145 
et al., 2014). 146 
SOD was analysed with a commercially available ELISA kit (Cayman Chemical, Ann Arbor, 147 
Michigan, USA) in line with manufacturer’s instructions utilising a plate reader and read at 148 
an absorption of 450 nm. The dynamic range of the SOD assay was 0.025-0.25 units/mL 149 
SOD, and the inter- and intra-assay coefficients of variance were less than 3.7% (Cayman 150 
Chemicals SOD ELISA kit, Cayman Chemical, USA). 151 
Plasma Osmolality: Approximately 20µL of plasma was used to determine if changes in 152 
plasma osmolality (Micro Osmometer Model 3300, Advanced Instruments, Inc., USA) 153 
between conditions affected the final concentrations of eHsp72 and SOD. Changes in whole 154 
venous plasma volume were quantified using established methods in triplicate (~50 µL) in 155 
line with Gibson et al (2014). Plasma volume was not significantly different (p=0.05) 156 
between any conditions.  157 
Supplementation: Subjects consumed one pre-prepared 250mL bottle (70mL EM-X 158 
(Effective Microorganisms UK) mixed with 180mL water) of EM-X drink, or, volume, taste 159 
and odour matched 250mL bottle of placebo drink for seven consecutive days prior to 160 
laboratory attendance. The EM-X drink was prepared in accordance with the manufacturer’s 161 
recommended dosage (personal communication). 162 
Subjects reported to the laboratory on six occasions having fasted for 2 hours and replicating 163 
food intake and activity levels (habitual exercise only) prior to each experimental visit. 164 
Compliance for all the aforementioned experimental controls was at 100% in all subjects. The 165 
protocol was approved by the institutional Ethics Committee and all subjects signed informed 166 
consent following the principles outlined in the Declaration of Helsinki. 167 
Experimental design – Visit 1 168 
Anthropometric measures: During the initial visit subject’s height and body mass were 169 
obtained to the nearest 0.1cm/kg in the Frankfurt plane (Harpenden Instruments, West 170 
Sussex, UK).  171 
VO2max test: Maximal aerobic capacity was determined using an incremental test to 172 
exhaustion on a treadmill (Woodway, Waukesha, WI, USA). Participants began the test at a 173 
speed of 9km.h-1, 1% gradient. The test consisted of 2 minute stages, during the second 174 
minute of each stage expired air was collected for approximately 60s via open circuit 175 
spirometry. HR was monitored throughout the test using a HR monitor (Polar Sports Tester, 176 
Polar, Electro Inc, Finland). Treadmill speed was increased by 1 km.h-1 at the onset of each 177 
new stage. Subjects were instructed to continue for as long as possible with. verbal 178 
encouragement throughout. VO2max was taken as the highest VO2 value obtained in any 10 179 
second period and was taken as having been achieved when meeting end-point criteria in 180 
accordance with the guidelines of the British Association of Sport and Exercise Sciences 181 
(Bird & Davison, 1997). Expired air was analysed using an infrared and paramagnetic 182 
analyser (model 1400, Servomex Controls, Crowbourough, UK). Results of the VO2max test 183 
were used to calculate running speeds for the active recovery stage by using the linear 184 
regression equation generated from the graph of running speed (km.h-1) and VO2 (mL.kg-185 
1.min-1).  186 
Visit 2 187 
Maximal Anaerobic Running Test (MART): Two days after the VO2max test, subjects began a 188 
standardised warm up on a motorised treadmill (Woodway, Waukesha, WI, USA) and then 189 
began the MART (Nummela, Alberts, Rijntjes, Luhtanen, & Rusko, 1996) at a speed of 12 190 
km.h-1,10% gradient running for 20 seconds, runs were followed by 100 seconds of passive 191 
recovery before beginning a new stage whereby speed was increased by 0.5 km.h-1. The test 192 
was terminated when the subject could no longer keep pace with the treadmill, the final 193 
completed running speed was used to prescribe the running velocity during the intermittent 194 
running protocol. 195 
Visits 3 to 6 196 
Subjects completed one high intensity interval running protocol (HITRP) on each of the four 197 
remaining visits in a randomised order utilising a double blind, cross over design, within a 198 
purpose built environmental chamber with temperature and humidity controlled using 199 
automated computer feedback (WatFlow control system; TISS, Hampshire, UK). Two visits 200 
were completed in temperate conditions (TEMP; 20.4 ± 1.7°C, 41, ± 4.2 % RH), and two in 201 
hot and humid conditions (HOT; 34.7 ± 2.0°C, 51.7 ± 4.5 % RH). One hot and one temperate 202 
trial were completed following a period of supplementation with EM-X (TEMPEMX or 203 
HOTEMX) or placebo (TEMPPLA or HOTPLA).  The HITRP were conducted in their entirety for 204 
all participants in each of the four experimental trials.  205 
Statistical Methods 206 
All statistical analyses were completed using IBM SPSS Statistics 19 (SPSS Inc., Chicago, 207 
IL). The normality of each dependent variable was checked using quantile-quantile (Q-Q) 208 
plots and deemed plausible in each instance. The central tendency and dispersion of each 209 
dependent variable are therefore reported as the mean (SD). The effects of Ingestion (placebo 210 
vs. EM-X) and Temperature (temperate vs. hot) on the response of each dependent variable 211 
over the twenty intervals (or pre- and post-intervention for eHsp72 and SOD) were 212 
investigated using linear mixed models. The best fitting covariance structure for each model 213 
was identified by minimising the Hurvich and Tsai’s criterion. The assumptions of normally 214 
distributed residuals around a mean of zero and constant variance were checked using Q-Q 215 
plots and scatter plots and deemed plausible. Statistical significance was accepted as p≤0.05. 216 
Results 217 
Plasma eHsp72 increased from pre- to post-exercise (F=62.1, p=0.001), however, this time 218 
effect was moderated by Temperature (F=30.8, p=0.001) see Fig.1. In TEMP eHsp72 219 
increased by 0.8 ng·mL-1 (95% CI=0.3 to 1.2 ng·mL-1, p=0.005), compared to 1.5 ng·mL-1 in 220 
HOT (95% CI=1.1 to 1.9 ng·mL-1, p=0.001). The main effects for Ingestion (F=1.7, p=0.20) 221 
and the interaction effect (F=0.3, p=0.59) were not significant. The mean difference in 222 
plasma eHsp72 between the placebo and EM-X conditions was not different in TEMP and 223 
HOT (F=0.4, p=0.53). 224 
SOD activity increased over time (F=70.1, p=0.001), the effect of which, was moderated by 225 
Temperature (F=9.4, p=0.004) see Fig. 2. In TEMP there was a 0.10 U·mL-1 mean increase 226 
in SOD activity (95% CI=0.047 to 0.16 units, p=0.001), compared to a 0.22 U·mL-1 mean 227 
increase in HOT (95% CI=0.16 to 0.28 U·mL-1, p=0.001). There was no pre-intervention 228 
difference between SOD activity in TEMP and HOT (p=0.74). SOD activity was higher in 229 
HOT than TEMP post-intervention (p=0.001). Ingestion type did not influence SOD activity 230 
over time, either alone (F=1.7, p=0.20), or as an interaction with Temperature (F=1.4, 231 
p=0.24). Mean SOD was lower in the EM-X conditions compared to placebo (F=9.7, 232 
p=0.004), but higher in HOT compared to TEMP (F=6.7, p=0.014). A significant interaction 233 
was observed (F=4.5, p=0.042). In HOT there was a 0.10 U·mL-1 higher mean SOD activity 234 
in the placebo condition compared to the EM-X condition (95% CI=0.045 to 0.16 U·mL-1, 235 
p=0.001), with no difference between placebo and EM-X in TEMP (mean difference=0.019 236 
U·mL-1, 95% CI=-0.036 to 0.075 U·mL-1, p=0.48). 237 
HR during the relief intervals increased by an average of 17 b·min-1 over the period of the 20 238 
intervals (F=491.7, p=0.001), but, like Tc, this effect was not moderated by Ingestion 239 
(F=0.08, p=0.78), but was moderated by Temperature (F=10.9, p=0.001) see Fig. 3. In 240 
TEMP HR increased at a mean rate of 0.9 b·min-1 per interval, compared to 0.7 b·min-1 per 241 
interval in HOT (mean slope difference=0.2 b·min-1, 95% CI=0.1 to 0.4 b·min-1, p=0.001). 242 
This difference was due to an interaction effect, whereby the mean rate of increase in HR 243 
decelerated at a mean rate of 0.07 b·min-1 per interval in HOT and 0.02 b·min-1 per interval in 244 
TEMP (mean difference=0.05 b·min-1, 95% CI=0.02 to 0.07 b·min-1, p=0.001). Although the 245 
rate of increase in HR during successive relief intervals was higher in TEMP, HR was, on 246 
average, 14 b·min-1 higher in HOT than TEMP (95% CI=13 to 15 b·min-1, p=0.001). The 247 
main effect for Ingestion (F=1.5, p=0.28) and the interaction effect (F=2.5, p=0.11) were not 248 
statistically significant. 249 
Tc increased by ~1.6°C over the period of the 20 intervals (F=163.8, p=0.001). The rate of 250 
increase was moderated by Temperature. In TEMP Tc increased at a mean rate of 0.062°C per 251 
interval, compared to 0.081°C in HOT (mean slope difference=0.019°C, 95% CI=0.013 to 252 
0.025°C, p=0.001). Mean Tc was, on average, 0.32°C higher in HOT compared to TEMP 253 
(95% CI=0.29 to 0.35°C, p=0.001). Although the main effect for Ingestion was not 254 
significant (F=2.3, p=0.19), an interaction was observed (F=18.4, p=0.001). In TEMP no 255 
difference in Tc was observed between placebo and EM-X (mean difference=0.004°C, 95% 256 
CI=-0.10 to 0.11°C, p=0.93), whereas in HOT mean Tc was 0.12°C higher for placebo 257 
compared to EM-X (95% CI=0.016 to 0.22°C, p=0.03). 258 
TS increased by around 2 units during the 20 intervals (F=143.9, p=0.001), with the rate of 259 
increase moderated by Temperature (Fig. 4). TS increased at a mean rate of 0.12 units per 260 
interval in HOT and 0.09 units in TEMP (mean slope difference=0.03 units, 95% CI=0.02 to 261 
0.04 units, p=0.001). There was no significant effect for Ingestion (F=0.2, p=0.70) and the 262 
interaction also was not significant (F=2.1, p=0.15). However, an Ingestion-by-Temperature 263 
interaction was observed (F=13.3, p=0.001), highlighting that in TEMP TS was 0.4 units 264 
lower in the EM-X condition compared to placebo (95% CI=0.2 to 0.6 units, p=0.006), 265 
whereas in HOT the 0.2 unit difference between placebo and EX--X did not reach statistical 266 
significance (95% CI=-0.03 to 0.4 units, p=0.08). 267 
RPE increased by around 7 units during the 20 intervals (F=37.7, p=0.002), with the rate of 268 
increase moderated by Temperature (Fig. 4). The RPE increased at a rate of 0.35 units per 269 
interval in HOT and by 0.28 units in TEMP (mean slope difference=0.06 units, 95% CI=0.04 270 
to 0.09 units, p=0.001). The RPE was, on average, 0.7 units higher in HOT compared to the 271 
TEMP (95% CI=0.6 to 0.9 units, p=0.001). The main effect for Ingestion (F=3.6, p=0.12) 272 
and the interaction effect (F=2.4, p=0.12) were not statistically significant. 273 
Discussion 274 
eHsp72 and SOD concentrations increased pre to post exercise in HOT and TEMP (see Fig. 1 275 
and Fig. 2). Elevated eHsp72 in HOT (+418%) has been reported elsewhere but not at the 276 
magnitude to which our data observed (Whitham et al., 2007 (+200%); Magalhães et al., 277 
2010 (+34%); Periard et al., 2012 (~125%); Gibson et al., 2014 (172%)). Our observed 278 
increases in TEMP (+212%) are less frequently observed but comparable with others 279 
(Whitham et al., 2006 (+200%); Whitham et al., 2007 (+100%)). A minimum endogenous 280 
criteria is required to increase eHsp72, this criteria – sufficient change in the absolute 281 
(≥38.5°C ;(Amorim, Yamada, Robergs, Schneider, & Moseley, 2008)) and rate of Tc increase 282 
(1.6°C.hr-1 (Gibson et al. 2014); 2.0 & 2.5°C.hr-1 (Périard et al. 2012)), and significant (≥ 153 283 
beats.min-1) sympathetic activity (Gibson, et al., 2014) can be achieved via exercise, a 284 
thermal environment, or a combination of the two. Even in TEMP conditions our mean HR 285 
responses of ≥150 beats.min-1 and final rectal temperatures of ~38.5°C meet the above 286 
required endogenous criteria, and the proposed α-adrenergic stimulation (Johnson & 287 
Fleshner, 2006). Greater eHsp72 concentration in HOT are likely a result of either greater 288 
magnitude of HR (HOT >170 beats.min-1; TEMP >160 beats.min-1; Fig. 3) and/or Tc (HOT 289 
>38.5°C; TEMP >38.0°C; Fig. 3) responses, or the earlier attainment of each stimuli, hence 290 
greater duration above the previously stated minimum endogenous threshold. 291 
SOD is an established biomarker of oxidative stress. Increased physiological strain (Fig. 3) 292 
when exercising under hyperthermia vs normothermia (Lafrenz, Wingo, Ganio, & Cureton, 293 
2008) led to greater concentrations in HOT (+14.7%) than TEMP (+6.8%; Fig. 2). 294 
Amelioration in SOD increases within the HOTEMX (+11.8%) condition compared to HOTPLA 295 
(+17.7%) is likely facilitated by the potent antioxidant capacity of EM-X. Amelioration was 296 
not observable in TEMP where the difference between TEMPEMX (+6.7%) and TEMPPLA 297 
(+6.9%) were negligible due to reduced physiological strain. EM-X composition is diverse 298 
containing ~40 minerals and compounds, of which many have antioxidant effects both in-299 
vitro and in vivo (ubiquinone, α-tocopherol (vitamin E), lycopene, saponin and the flavonoid 300 
quercetin (Aruoma, et al., 2002). We are unable to determine precisely which antioxidant 301 
compound has potentially mediated this amelioration of oxidative stress, however, α-302 
tocopherol, lycopene, ubiquinone (Peternelj & Coombes, 2011) and flavonoids (Kressler, 303 
Millard-Stafford, & Warren, 2011) are all known to exert an antioxidant influence in vivo 304 
within humans. The use of a mixed antioxidant profile, rather than one specific antioxidant 305 
compound, to ameliorate the reactive oxygen species response to exercise is supported 306 
(Balakrishnan & Anuradha, 1998), giving efficacy to this ergogenic aid. Whilst reactive 307 
oxygen species generation and/or disturbances to redox balance are essential components of 308 
exercise adaption (Powers, et al., 2010), this is an undesirable response during repeated 309 
competition due to the potential performance detriments (Cobley, et al., 2011). Ameliorating 310 
redox balance disturbances can attenuate fatigue after repeated bouts of intermittent high-311 
intensity exercise within temperate environments (Cobley, et al., 2011).  312 
Antioxidant supplementation during HIT related exercise performance, may be better suited 313 
to tournament situations, whereby, fatigue “resistance/recovery from” is paramount and 314 
adaptation is a negligible goal (Cobley, et al., 2011). Team sports require repeated sprint/HIT 315 
based movement patterns, often in tournament situations in challenging environments, with 316 
recovery time between competition suboptimal. EM-X supplementation elicited no such 317 
negative side effects previously observed with N-Acetylcysteine supplementation (Cobley, et 318 
al., 2011). Our data suggests the presence of reactive oxygen species, and the established 319 
pathways which elicit decrements in repeated sprint exercise performance with limited 320 
recovery time (Cobley, et al., 2011) appear to/could be attenuated by the supplementation of 321 
EM-X during exercise in the heat. 322 
No direct cause and effect relationship between EM-X supplementation and peripheral 323 
mechanisms of exercise fatigue attenuation can be claimed from the present study. Future 324 
studies should seek to quantify the potential ergogenic effect of EM-X, across a range of 325 
relative dosages, on fatiguing high-intensity interval training exercise, within hot 326 
environments akin to the study design of others (Cobley, et al., 2011). The efficacy of EM-X 327 
as an ergogenic aid to attenuate oxidative stress resulting from prolonged continuous exercise 328 
in the heat could additionally be considered as a means to ameliorate short-term negative 329 
physiological effects which contribute to cumulative performance decrements observed 330 
during consecutive multiday competition. 331 
Classical physiological responses to exercise in hot vs. temperate conditions were observed, 332 
with increased HR and Tc (Galloway & Maughan, 1997; Gibson, et al., 2014; Lafrenz, et al., 333 
2008), and TS and RPE (Gagge, et al., 1969; Galloway & Maughan, 1997; Gibson, et al., 334 
2014). Insufficient heat dissipation in HOTEMX and HOTPLA increased heat storage in 335 
comparison with TEMP (1.86°C.hr-1 in TEMP vs 2.43°C.hr-1 in HOT, see Fig. 3) irrespective 336 
of the matched work, VO2 and metabolic heat production (MHP). Increased physiological 337 
(HR HOT >170 beats.min-1; TEMP >160 beats.min-1) and thermal responses (Tc HOT 338 
>38.5°C; TEMP >38.0°C) during our HIT in comparison to data reported for continuous 339 
exercise of approximately similar average intensity in the heat (Gibson, et al., 2014; Houmard 340 
et al., 1990) are not unexpected as intermittent exercise is known to elicit greater thermal and 341 
cardiovascular strain than continuous exercise of the same average intensity over a fixed 342 
duration (Taylor and Cotter 2006). This difference is further increased when running in 343 
comparison to cycling, where increased absolute VO2 (Kang, Hoffman, Walker, Chaloupka, 344 
& Utter, 2003), thus MHP, is also greater at a given % of VO2max (Smoljanic, Morris, Dervis, 345 
& Jay, 2014). 346 
Conclusion 347 
High intensity exercise in hot conditions elicited greater eHsp72 and SOD than matched 348 
exercise performance in temperate conditions, likely due to the increases in relative exercise 349 
intensity, and associated increases in physiological strain induced by hyperthermia. 350 
Supplementation of EM-X attenuated the SOD increases in hot conditions, suggesting 351 
oxidative stress had been reduced. 352 
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Superoxide dismutase. Tc; Core temperature. TEMP; Temperate conditions. TEMPEMX; 359 
Supplementation with EM-X in temperate conditions. TEMPPLA; Supplementation with 360 
placebo in temperate conditions. TS; Thermal sensation.VO2max; Maximum oxygen uptake  361 
 362 
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 452 
 453 
Figure 1. Mean (SD) plasma eHsp72 concentrations at pre- and post-exercise for the four 454 
experimental conditions. Spots represent individual subject data * Post-exercise plasma 455 
eHsp72 in hot conditions significantly higher than post- exercise plasma eHsp72 in temperate 456 
conditions 457 
  458 
 459 
Figure 2. Mean (SD) superoxide dismutase (SOD) concentrations at pre- and post-exercise 460 
for the four experimental conditions. Spots represent individual subject data. * Mean post-461 
exercise SOD activity in hot conditions significantly higher than mean post-exercise SOD 462 
activity SOD activity in temperate conditions. # Mean post-exercise SOD activity lower 463 
following EM-X vs. Placebo in hot conditions. 464 
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 467 
Figure 3. Physiological responses (Mean HR; top. Tc; bottom) over the 20 intervals in the 468 
four experimental conditions. Error bars have been omitted for clarity. * Slopes for hot 469 
conditions significantly higher than for the temperate conditions. 470 
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 472 
Figure 4. Perceptual responses (Mean TS; top. RPE; bottom) over the 20 intervals in the four 473 
experimental conditions. Error bars have been omitted for clarity. * Slopes for hot conditions 474 
significantly higher than for the temperate conditions. 475 
